Results 141 to 150 of about 79,377 (290)

Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis [PDF]

, 2017
Jorge Peñalver, Wassim Shatila, Emerson C. Perin   +2 more
openalex   +1 more source

Role of Endoscopic Ultrasound‐guided Gastroenterostomy for Benign Gastric Outlet Obstruction

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Benign gastric outlet obstruction (GOO) often results from intrinsic conditions like peptic strictures, caustic‐induced stricture, and surgical anastomoses, and extrinsic conditions like pancreatitis, hematoma, and superior mesenteric artery syndrome.
Suprabhat Giri, Saroj Kanta Sahu, Gaurav Khatana, Prasanna Gore, Preetam Nath, Bipadabhanjan Mallick, Jimmy Narayan, Aditya Kale, Sridhar Sundaram   +8 more
wiley   +1 more source

Association of Periprocedural Inflammatory Activation With Increased Risk for Early Coronary Stent Thrombosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Stent thrombosis is a rare but deleterious event. Routine coronary angiography with percutaneous coronary intervention (PCI) is often deferred in the presence of laboratory markers of acute inflammation to prevent complications.
Konstantin A. Krychtiuk, Konstantin Bräu, Stephanie Schauer, Alexander Sator, Lukas Galli, Andreas Baierl, Christian Hengstenberg, Clemens Gangl, Irene M. Lang, Christian Roth, Rudolf Berger, Walter S. Speidl   +11 more
doaj   +1 more source

Stent-assisted reconstructive endovascular repair of intracranial aneurysms: long-term clinical and angiographic follow-up [PDF]

, 2012
Background and Purpose: The development of self-expanding stents dedicated to intracranial use has significantly widened the applicability of endovascular therapy to many intracranial aneurysms.
VANNUCCI, STEFANO
core  

Academic Research Council Subacute Stent Thrombosis [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Examination of mechanical and medical application properties of coronary stents [PDF]

, 2005
The medical application properties of coronary stents describe their behaviour in the human vascular system from planting to functioning. However these properties have great importance to surgeons, not all of them have standardized examination methods ...
Bálint-Pataki, Zs., Dobránszky, János, Puskás, Zsolt   +2 more
core  

Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery

, 2018
Simon Howell, Sanne E. Hoeks, Robert West, Stephen G. Wheatcroft, Andreas Hoeft, B. Leva, B. Plichon, Sabrine Damster, Mona Momeni, Christine Watremez, D. Kahn, Anne-Sophie Dincq, Aida Danila, Mária Wittmann, Rafael Struck, T. Rüddel, F. J. Kessler, Stefan Rasche, Paraskevi Matsota, Antigona Hasani, Jūratė Gudaitytė, Aurika Karbonskienė, Rafael Meneguzzi Alves Ferreira, Susana Carvalho, Dana Tomescu, C. Martac, Ioana Marina Grințescu, Lucia Mirea, Leyre Serrano Fernández, Leyre Serrano Fernández, P. Sierra, Sergi Sabaté, David Hernando, P. Matute, M. Trashorras, M. Suñé, L Argüello, Adriana Hervías, Óscar González‐Lorenzo, Andrew Hermina, Óscar González‐Lorenzo, Andrew Hermina, R. Perez, María Isabel Orts, Raquel Fernández-García, D. Sánchez Pérez, I. Sepulveda Gil, Pablo Monedero, Francisco Hidalgo, C. Mbongo, A. Rodríguez, Hugo Reyes, Carlos Bártolo, S López Galera, Tabita M. Valentijn, Robert Jan Stolker, Mehmet Tuğrul, Ebru-Berrin Demirel, M. Hough, K. Griffiths, Stephen Birch, Z. Beardow, S. Elliot, Jonathan P. Thompson, Sarah Bowrey, Martin Northey, H. Melson, Richard J. Telford, Maria Nadolski, A. Potter, Daniela T. Fuller, Adam J. Rose, S. Varma, Karen Simeson, Joshua Pettit, Nicola Jayne Smith, Victoria Martinson, Lisa Sleight, C. David Naylor, P. R. Watt, Parizade Raymode, Nigel Dunk, Linda Twohey, Laszlo Hollos, Simon Davies, Andrew K. Gibson, Zoe Coleman, Tamm Ti, J. Joscak, Lajos Zsisku, M. Zuleika, P. Carvalho, T. Collyer, Jason Ryan, Kristin P. Colling, S. Dharmarajah, Anand Muthu Krishnan, Jonathan Paddle, Anna Fouracres, Kai Arnell   +99 more
openalex   +1 more source

Acute stent thrombosis

Heart Views, 2014
Fahad Al Kindi, Salah El Deen Arafa, Abdul Rahman Arabi   +2 more
openaire   +3 more sources

Simultaneous Intracranial and Spinal Hemorrhage Following Tenecteplase Thrombolysis for ST‐Elevation Myocardial Infarction: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Central nervous system (CNS) hemorrhage is a serious complication of intravenous thrombolysis. Tenecteplase, a fibrin‐specific thrombolytic agent, has a lower risk of hemorrhage than other agents. We report the first documented case of simultaneous intracranial and spinal hemorrhage following intravenous administration of tenecteplase.
Thamalee Palliyaguru, Pramith Ruwanpathirana, Praveen Weeratunga, Mythily Aravinthan, Thashi Chang   +4 more
wiley   +1 more source